Dorsal root ganglia, sodium channels, and fibromyalgia sympathetic pain

Medical Hypotheses

Volumn 72, Issue 1, 2009, Pages 64-66

  Martinez Lavin, Manuel ^a   Solano, Carla ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; NERVE GROWTH FACTOR; SODIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; VOLTAGE DEPENDENT ANION CHANNEL 1.7;

ALLODYNIA; ARTICLE; CEREBROSPINAL FLUID; CHANNELOPATHY; CHRONIC PAIN; ERYTHROMELALGIA; FIBROMYALGIA; HUMAN; HYPERACTIVITY; INJURY; NERVE CELL PLASTICITY; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SPINAL GANGLION; VIRUS INFECTION;

CHANNELOPATHIES; FIBROMYALGIA; GANGLIA, SPINAL; HUMANS; MODELS, NEUROLOGICAL; PAIN; SODIUM CHANNELS; SYMPATHETIC NERVOUS SYSTEM; SYNDROME;

EID: 56249117980     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.07.055     Document Type: Article

References (23)

1. Martinez-Lavin M. Fibromyalgia as a sympathetically maintained pain syndrome. Curr Pain Headache Rep 8 (2004) 385-389
2. Wada A., Wanke E., Gullo F., and Schiavon E. Voltage-dependent Na(v)1.7 sodium channels: multiple roles in adrenal chromaffin cells and peripheral nervous system. Acta Physiol (Oxf) 192 (2008) 221-231
3. Drenth J.P.H., and Waxman S.G. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 117 (2007) 3603-3609
4. Garcia-Poblete E., Fernandez-Garcia H., Moro-Rodriguez E., Catala-Rodriguez M., Rico-Morales M.L., García-Gomez-de-las-Heras S., et al. Sympathetic sprouting in dorsal root ganglia (DRG): a recent histological finding?. Histol Histopathol 18 (2003) 575-586
5. Diss J.K., Calissano M., Gascoyne D., Djmgoz M.B., and Latchman D.S. Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A). Mol Cell Neurosci 37 (2008) 537-547
6. Rush A.M., Dib-Hajj S.D., Liu S., Cummins T.R., Black J.A., and Waxman S.G. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A 103 (2006) 8245-8850
7. Nauta H.J., Wehman J.C., Koliastos V.E., Terrel M.A., and Chung K. Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia. J Neurosurg 91 (1999) 447-453
8. Yang X.D., Liu Z., Liu H.X., Wang L.H., Ma C.H., and Li Z.Z. Regulatory effect of nerve growth factor on release of substance P in cultured dorsal root ganglion neurons of rats. Neurosci Bull 23 (2007) 215-220
9. Van Zundert J., Harney D., Joosten E.A., Durieux M.E., Patijn J., Prins M.H., et al. The role of the dorsal root ganglion in cervical radicular pain: diagnosis, pathophysiology, and rationale for treatment. Reg Anesth Pain Med 31 (2006) 152-167
10. Garry E.M., Delaney A., Anderson H.A., Sirinathsinghji E.C., Clapp R.H., Martin W.J., et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118 (2005) 97-111
11. Brannagan III T.H., Nuovo G.J., Hays A.P., and Latov N. Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization. Ann Neurol 42 (1997) 368-372
12. Cadavid D., O'Neill T., Schaefer H., and Pachner A.R. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab Invest 80 (2000) 1043-1054
13. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Belfer I., Max M.B., et al. Genetic basis for individual variation of pain perception and the development of a chronic pain condition. Hum Mol Genet 14 (2005) 135-143
14. Buskila D., Neumann L., Vaisberg G., Alkalay D., and Wolfe F. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 40 (1997) 446-452
15. Boisset-Pioro M.H., Esdaile J.M., and Fitzcharles M.A. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum 38 (1995) 235-241
16. Marquez J., Restrepo C.S., Candia L., Berman A., and Espinoza L.R. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumatol 31 (2004) 741-746
17. Caims V., and Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 34 (2005) 1340-1345
18. Vargas-Alarcón G., Fragoso J.M., Cruz-Robles D., Vargas A., Vargas A., Lao-Villadóniga J.I., et al. Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 9 5 (2007) R110
19. Giovengo S.L., Russell I.J., and Larson A.A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26 (1999) 1564-1569
20. Martinez-Lavin M. Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res Ther 9 (2007) 216
21. Shen J., Wang H.Y., Chen J.Y., and Liang B.L. Morphologic analysis of normal human lumbar dorsal root ganglion by 3D MR imaging. AJNR Am J Neuroradiol 27 (2006) 2098-2103
22. Raphael J.H., Southall J.L., Treharne G.J., and Kitas G.D. Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskelet Disord 3 (2002) 21
23. Silos-Santiago I. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs?. Curr Opin Investig Drugs 9 1 (2008) 83-89